ACRV
Price
$1.30
Change
-$0.03 (-2.26%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
41.08M
43 days until earnings call
MGNX
Price
$1.27
Change
-$0.04 (-3.05%)
Updated
Jun 26 closing price
Capitalization
80.12M
46 days until earnings call
Interact to see
Advertisement

ACRV vs MGNX

Header iconACRV vs MGNX Comparison
Open Charts ACRV vs MGNXBanner chart's image
Acrivon Therapeutics
Price$1.30
Change-$0.03 (-2.26%)
Volume$14.65K
Capitalization41.08M
MacroGenics
Price$1.27
Change-$0.04 (-3.05%)
Volume$1.07M
Capitalization80.12M
ACRV vs MGNX Comparison Chart in %
Loading...
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRV vs. MGNX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a Buy and MGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ACRV: $1.31 vs. MGNX: $1.27)
Brand notoriety: ACRV and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 48% vs. MGNX: 89%
Market capitalization -- ACRV: $41.08M vs. MGNX: $80.12M
ACRV [@Biotechnology] is valued at $41.08M. MGNX’s [@Biotechnology] market capitalization is $80.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACRV is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 3 TA indicator(s) are bullish while MGNX’s TA Score has 2 bullish TA indicator(s).

  • ACRV’s TA Score: 3 bullish, 2 bearish.
  • MGNX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, ACRV is a better buy in the short-term than MGNX.

Price Growth

ACRV (@Biotechnology) experienced а +5.65% price change this week, while MGNX (@Biotechnology) price change was -7.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

ACRV is expected to report earnings on Aug 08, 2025.

MGNX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($80.1M) has a higher market cap than ACRV($41.1M). MGNX YTD gains are higher at: -60.923 vs. ACRV (-78.239). MGNX has higher annual earnings (EBITDA): -47.33M vs. ACRV (-92.1M). MGNX (154M) and ACRV (150M) have equal amount of cash in the bank . ACRV has less debt than MGNX: ACRV (3.51M) vs MGNX (37.5M). MGNX has higher revenues than ACRV: MGNX (152M) vs ACRV (0).
ACRVMGNXACRV / MGNX
Capitalization41.1M80.1M51%
EBITDA-92.1M-47.33M195%
Gain YTD-78.239-60.923128%
P/E RatioN/AN/A-
Revenue0152M-
Total Cash150M154M97%
Total Debt3.51M37.5M9%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACRVMGNX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 24 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GIII22.490.74
+3.40%
G-III Apparel Group Ltd
ELP9.030.16
+1.80%
Companhia Paranaense de Energia - COPEL
HIVE1.790.01
+0.56%
HIVE Digital Technologies Ltd
AON353.55-0.91
-0.26%
Aon plc
GRCE2.94-0.02
-0.68%
Grace Therapeutics Inc

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
-1.50%
ALLR - ACRV
48%
Loosely correlated
-1.10%
AURA - ACRV
40%
Loosely correlated
-4.26%
MGNX - ACRV
38%
Loosely correlated
-3.05%
CCCC - ACRV
38%
Loosely correlated
-1.30%
ARWR - ACRV
37%
Loosely correlated
+2.62%
More